SOURCE: Antisoma plc

June 22, 2006 07:01 ET

Antisoma to present at Jeffries Life Sciences Conference on 27 June 2006

LONDON, UK -- (MARKET WIRE) -- June 22, 2006 --

22 June 2006, London, UK - Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its Chief Executive Officer, Glyn Edwards, will be presenting at the Jeffries Life Sciences Conference in New York, USA.

Mr Edwards's presentation is scheduled for 14.30 EST on Tuesday, June 27. A webcast of the presentation will be available to all on Antisoma's website at

It is recommended that viewers log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live web cast, a recorded replay of the presentation will be available for 90 days.


Margherita Lupi            +44 (0)20 8799 8200
Communications Manager
Antisoma plc
Background on Antisoma

Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. In November 2002, Antisoma formed a broad strategic alliance with Roche to develop and commercialise products from Antisoma's pipeline. Please visit for further information.

Copyright © Hugin ASA 2006. All rights reserved.

Contact Information